These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26163913)

  • 41. [How can we integrate nutritional support in medical oncology?].
    Demoor-Goldschmidt C; Raynard B
    Bull Cancer; 2009 Jun; 96(6):665-75. PubMed ID: 19553167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Weight loss treatment in long-term care:are outcomes improved with oral supplements and appetite stimulants?
    Padala KP; Keller BK; Potter JF
    J Nutr Elder; 2007; 26(3-4):1-20. PubMed ID: 18285290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological treatment of geriatric cachexia: evidence and safety in perspective.
    Yeh SS; Lovitt S; Schuster MW
    J Am Med Dir Assoc; 2007 Jul; 8(6):363-77. PubMed ID: 17619035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Geriatric cachexia: the role of cytokines.
    Yeh SS; Schuster MW
    Am J Clin Nutr; 1999 Aug; 70(2):183-97. PubMed ID: 10426694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel approaches to the treatment of cachexia.
    Argilés JM; López-Soriano FJ; Busquets S
    Drug Discov Today; 2008 Jan; 13(1-2):73-8. PubMed ID: 18190867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer cachexia: pathophysiologic aspects and treatment options.
    Topkan E; Yavuz AA; Ozyilkan O
    Asian Pac J Cancer Prev; 2007; 8(3):445-51. PubMed ID: 18159985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin.
    Diament MJ; Peluffo GD; Stillitani I; Cerchietti LC; Navigante A; Ranuncolo SM; Klein SM
    Cancer Invest; 2006 Mar; 24(2):126-31. PubMed ID: 16537180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Appetite stimulants and anabolic hormones.
    Fitting JW
    Monaldi Arch Chest Dis; 2003; 59(4):326-30. PubMed ID: 15148847
    [No Abstract]   [Full Text] [Related]  

  • 49. Appetite stimulants: the unsolved truth.
    Baron M
    Health Care Food Nutr Focus; 2000 Jun; 16(10):5-7. PubMed ID: 11182996
    [No Abstract]   [Full Text] [Related]  

  • 50. [Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome].
    Krznarić Z; Juretić A; Samija M; Dintinjana RD; Vrdoljak E; Samarzija M; Kolacek S; Vrbanec D; Prgomet D; Ivkić M; Zelić M;
    Lijec Vjesn; 2007 Dec; 129(12):381-6. PubMed ID: 18383739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Editorial: Megestrol acetate use for weight gain should be carefully considered.
    Evans WJ
    J Clin Endocrinol Metab; 2007 Feb; 92(2):420-1. PubMed ID: 17284644
    [No Abstract]   [Full Text] [Related]  

  • 52. L-carnitine and cancer cachexia. I. L-carnitine distribution and metabolic disorders in cancer cachexia.
    Szefel J; Kruszewski WJ; Ciesielski M; Szajewski M; Kawecki K; Aleksandrowicz-Wrona E; Jankun J; Lysiak-Szydłowska W
    Oncol Rep; 2012 Jul; 28(1):319-23. PubMed ID: 22562434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in understanding and treating cardiac cachexia: highlights from the 5th Cachexia Conference.
    von Haehling S; Stepney R; Anker SD
    Int J Cardiol; 2010 Oct; 144(3):347-9. PubMed ID: 20561693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Appraisal of current and experimental approaches to the treatment of cachexia.
    Strasser F
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):312-6. PubMed ID: 18685381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Current views on use of megestrol acetate in oncology practice].
    Vyzula R
    Vnitr Lek; 1997 Apr; 43(4):250-5. PubMed ID: 9601846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. L-carnitine and cancer cachexia. II. Effects of lipid emulsion used in total parenteral nutrition on parameters of hemostasis and inflammatory state in L-carnitine deficiency in myocytes.
    Szefel J; Kruszewski WJ; Ciesielski M; Szajewski M; Kawecki K; Jankun J; Lysiak-Szydłowska W
    Oncol Rep; 2012 Jul; 28(1):324-9. PubMed ID: 22562458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological treatment of cachexia: any progress?
    Bruera E
    Support Care Cancer; 1998 Mar; 6(2):109-13. PubMed ID: 9540168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence base for multimodal therapy in cachexia.
    Solheim TS; Laird BJ
    Curr Opin Support Palliat Care; 2012 Dec; 6(4):424-31. PubMed ID: 23111703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel targeted therapies for cancer cachexia.
    Argilés JM; López-Soriano FJ; Stemmler B; Busquets S
    Biochem J; 2017 Jul; 474(16):2663-2678. PubMed ID: 28751550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) Appetite Scale in veteran cancer patients.
    Chang VT; Xia Q; Kasimis B
    J Support Oncol; 2005; 3(5):377-82. PubMed ID: 16218262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.